UCSF Adopts Magseed as Standard of care for Localization of Impalpable Breast Lesions
News Jan 24, 2017
Photo: X-ray showing a complete surgical specimen with negative margins and Magseed™ in the centre, next to the cancer.
Endomag has announced that the University of California, San Francisco (UCSF) has become the first US site to adopt Magseed™ as its standard of care for localization of impalpable breast lesions. Magseed™ is a simpler, more effective alternative to traditional wire localization methods.
Breast cancer is the most common form of cancer in women, with 1.7 million new cases of breast cancer globally every year, and is expected to double by 2030. Due to a rise in national screening programmes and an increase in public awareness, breast cancer is being caught at an earlier stage meaning that the tumors are smaller, less defined and harder to feel, with as many as 50% of all breast tumors impalpable at the time of diagnosis. In these cases, a technique called wire localization is typically used by surgeons to locate the tumor.
Although widely used, wire localization commonly causes complications. On average 1 in every 4 breast wire localizations result in cancerous tissue being left behind and requiring additional surgery because the wire has become dislodged between when it was implanted and when it was removed during surgery. Additionally, there is a risk of infection due to the wire protruding from the skin, so the placement of the wire must be done on the same day as surgery. These issues result in unnecessary anxiety for patients, delays to the surgical lists and fewer patients being treated as a consequence.
Dr. Eric Mayes, CEO of Endomag noted “The wire localization technique has remained largely the same since it was introduced over 30 years ago and it causes a lot of anxiety for patients. We wanted to create a technique that could simplify the localization process and improve the patient experience.”
Magseed™ is smaller than a grain of rice and can be placed into the tumor for up to 30 days, allowing the patient to return home ahead of surgery. Once implanted, the seed is not easily dislodged and patients are not restricted in movement or activity. During surgery the seed is detected with the Sentimag® probe to guide accurate removal of the tumor and maximising the amount of healthy tissue left behind. Unlike radioactive alternatives that involve strict regulatory oversight and complex logistics, the Magseed™ technique can be widely adopted by any hospital, regardless of size.
Dr. Laura Esserman (Breast Surgeon, UCSF) “We are excited to have a set of safe, easy to use tools that will improve the efficiency of identifying breast lesions and dramatically improve the experience of patients and clinicians, as well as the workflow in the operating room.”
Dr. Michael Alvarado (Breast Surgeon, UCSF) “We have been looking for a better alternative to wire localization for some time, as the wire procedure adds additional stress for the patients on the day of surgery and often causes delays to our operating schedule. Very early in our evaluation of the magnetic seed technique we found that we could avoid a same-day placement, and the surgeries could be completed in less time, without compromising accuracy. This offers a tangible benefit to both our clinical team and, most importantly, our patients.”
CMC Biologics Announces Development and Manufacturing Agreement with Harpoon TherapeuticsNews
Companies have entered into agreement for the development and manufacturing of three TriTAC molecules for the treatment of cancers.READ MORE
Some Immune Cells May Help Tumors Instead of Destroying ThemNews
New data shows that neutrophils promote tumor progression and can actually hamper the work of immunotherapy in lung cancer.READ MORE